Why Is Badger Meter (BMI) Stock Down -18% Today?
Key Takeaways
- Shares of BMI are tumbling approximately 18% in Friday's premarket session following a deeply disappointing Q1 2026 earnings report released before market open.
- Revenue came in at $202.3 million, a 9% year-over-year decline and a significant miss against analyst consensus expectations of roughly $230–$232 million.
- Diluted EPS fell to $0.93, sharply below analyst forecasts of approximately $1.20–$1.22 and down from $1.30 in Q1 2025.
- Operating margin contracted severely, dropping to 17.4% from 22.2% in the same period a year ago, driven by the revenue shortfall and rising selling, engineering, and administration (SEA) expenses.
- The company also announced a binding agreement to acquire UDlive, expected to close at the end of April 2026.
- Traders will now focus on management's commentary around the timing and magnitude of the anticipated recovery, as well as the integration of the pending acquisition.
Opening Summary
Badger Meter, Inc. (BMI) is a Milwaukee-based manufacturer of smart water solutions, specializing in flow measurement and control products serving utilities, municipalities, and industrial customers. On Friday, April 17, 2026, the company released its first-quarter 2026 earnings before the opening bell, triggering an approximately 18% decline in premarket trading — pushing shares from their prior session close of roughly $154.88 to around the $127 range. The collapse in share price reflects both a steep top-line miss and a dramatic compression in profitability that caught markets off guard after analysts had expected modest year-over-year revenue growth.
Earnings Results: A Sharp Disappointment
Badger Meter posted Q1 2026 total sales of $202.3 million, falling 9% below the year-ago period's $222.2 million and coming in roughly $28–$30 million short of Wall Street's consensus revenue forecast of approximately $230–$232 million. This marks a dramatic reversal from the company's Q1 2025 report, when it delivered 13.2% revenue growth. Diluted EPS of $0.93 missed the consensus estimate of approximately $1.20–$1.22 per share by nearly 23%, representing a steep year-over-year decline from the $1.30 earned in Q1 2025.
Margin Compression Amplifies Concern
Beyond the revenue miss, the dramatic compression in profitability heightened investor alarm. Operating earnings fell to $35.2 million from $49.4 million in Q1 2025 — a 29% year-over-year drop — while the operating margin shrank to 17.4% from 22.2%. Management attributed the margin deterioration to the compounding effect of lower sales combined with higher SEA expenses, suggesting that fixed-cost leverage is working in reverse as volumes decline. Net earnings fell to $27.3 million, compared to $38.4 million in the prior-year quarter.
Corporate Development: UDlive Acquisition
Alongside its earnings release, Badger Meter announced it has entered into a binding agreement to acquire UDlive, with the transaction expected to finalize at the end of April 2026. While acquisitions can signal strategic growth ambitions, the timing of this announcement — paired with weak organic results — may have given investors pause, raising questions about capital allocation priorities at a moment when the core business is under pressure. The market's reaction suggests that the near-term earnings shortfall overshadowed any enthusiasm for the deal.
Sector and Macro Context
BMI had already been under pressure entering today's report, with shares down roughly 14–15% year-to-date and trading nearly 40% below their 52-week high of approximately $256. The Q4 2025 earnings release in late January had already triggered an 11% single-day drop after revenue missed estimates by approximately $10.9 million, and management flagged a second-half-weighted 2026 outlook. Today's Q1 miss reinforces that the anticipated first-half weakness materialized worse than expected, and the stock's extended decline since early 2025 reflects a broader reassessment of growth and valuation. The water technology and measurement sector has not seen broad sympathy selling at this scale, making BMI's premarket move largely company-specific.
Market Context and Trading Activity
Volume is likely to be significantly elevated given the magnitude of the premarket move and the binary nature of earnings events. Heading into today, BMI was already trading well below its 50-day simple moving average of approximately $169.68 and its 200-day SMA of approximately $195.78, meaning technical support structures were already degraded. The approximately 18% premarket drop would push the stock toward and potentially below its recent 52-week low near $139, a level that will draw close attention at the open as a key support zone. Analysts had been cautious entering the print, with Zacks noting a negative Earnings ESP and consensus revisions trending lower in the 30 days prior.
Trending AI Robots
For traders navigating volatile earnings-driven moves like today's action in BMI, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the strongest real-time performance are surfaced in the Trending section. Bots vary across strategy types, holding timeframes, risk profiles, performance metrics, and the universe of symbols they trade — from high-volatility momentum plays to more systematic, rule-based approaches. Whether you are looking for tools to react to sudden market dislocations or to identify setups in calmer conditions, exploring the Trending AI Robots page is a practical starting point for integrating AI-assisted trading into your strategy.
What Comes Next for BMI
The immediate focus will be on management's Q1 2026 earnings call, scheduled for 10:00 a.m. CT on April 17, 2026, where executives will be pressed on the drivers of the revenue shortfall and whether the second-half recovery thesis remains intact. Analysts will scrutinize commentary on order backlog, pipeline activity, utility customer spending trends, and the outlook for margins as the year progresses. The pending UDlive acquisition close expected later in April adds an integration execution dimension to the story. Key risks include further deterioration in utility capital spending, continued fixed-cost deleverage if volumes remain soft, and any guidance revision that calls into question the full-year consensus. Analysts had already projected year-over-year EPS declines for Q1; if management revises the full-year trajectory downward, additional estimate cuts and price target reductions from the sell side are likely to follow.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
BMI sees its Stochastic Oscillator ascending out of oversold territory
On September 18, 2026, the Stochastic Oscillator for BMI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 69 instances where the indicator left the oversold zone. In 48 of the 69 cases the stock moved higher in the following days. This puts the odds of a move higher at over 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on September 18, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
Following a +4.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 186 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
BMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMI as a result. In 65 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
BMI moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Aroon Indicator for BMI entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. BMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.634) is normal, around the industry mean (4.203). P/E Ratio (31.091) is within average values for comparable stocks, (83.598). Projected Growth (PEG Ratio) (3.075) is also within normal values, averaging (5.580). Dividend Yield (0.012) settles around the average of (0.004) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (31.064).
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments
Advertisement